IP Library Granted Patent US 9,676,997
Granted Patent B2
US 9,676,997 · App. 14/721,727 · Granted Jun 13, 2017

Compositions and methods for stabilizing luminogenic substrates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,676,997
App. No.
14/721,727
Granted
Jun 13, 2017
Kind
B2
Abstract

Disclosed herein are compositions and methods for stabilizing a luminogenic substrate such as coelenterazine or a functional analog thereof. The functional analog may be furimazine. The composition may include the luminogenic substrate, a thionucleoside, and an organic solvent, in which the thionucleoside is present in an amount effective to stabilize the luminogenic composition against decomposition. The method provided herein stabilizes the luminogenic substrate against decomposition by contacting the luminogenic substrate with an effective amount of the thionucleoside in the presence of the organic solvent. Also provided herein is a kit containing the composition.

Claims (31)

1. A composition comprising

(a) a luminogenic substrate;

(b) an effective amount of a compound of formula (I) or a tautomer thereof,

wherein

R 1 is hydrogen, alkyl, substituted alkyl, alkyl-aryl, alkyl-heteroaryl, cycloalkyl, aryl, heteroaryl, carboxylic acid, ester, NR a R b , imine, hydroxyl, or oxo;

R 2 is hydrogen, NR a R b , imine, alkyl, or aryl;

R a and R b are each independently hydrogen, alkyl, or aryl; and

(c) an organic solvent;

wherein the luminogenic substrate is coelenterazine or a functional analog thereof.

2. The composition of claim 1 , wherein the composition does not contain a luminogenic enzyme.

3. The composition of claim 1 , wherein the luminogenic substrate is stabilized against decomposition in the presence of light, in the absence of light, or at temperatures from −80° C. to 60° C.

4. The composition of claim 1 , wherein the functional analog of coelenterazine is furimazine.

5. The composition of claim 1 , wherein the effective amount of the compound of formula (I) is greater than 0.1 mM.

6. The composition of claim 1 , wherein the compound of formula (I) is selected from the group consisting of: ATT, ATCA, 3-(4-Amino-5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)propanoic acid, tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione, 4-((2-furylmethylene)amino)-3-mercapto-6-methyl-1,2,4-triazin-5(41-1)-one, 6-benzyl-3-sulfanyl-1,2,4-triazin-5-ol, 4-amino-3-mercapto-6-methyl-1,2,4-triazin-5(4H)-one, 3-(5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)propanoic acid, (E)-6-methyl-4-((thiophen-2-ylmethylene)amino)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one, (E)-6-methyl-4-((3-nitrobenzylidene)amino)-3-thioxo -3,4-dihydro-1,2,4-triazin-5(2H)-one, (E)-4-((4-(diethylamino)benzylidene)amino)-6-methyl-3-thioxo -3,4-dihydro-1,2,4-triazin-5(2H)-one, ATCA ethyl ester, TAK-0014, TAK-0002, TAK-0021, TAK -0020, TAK-0018, TAK-0009, TAK-0007, TAK-0008, TAK-0003, TAK-0004, 3-thioxo-6-(trifluoromethyl)-3,4-dihydro-1,2,4-triazin-5(2H)-one, 6-cyclopropyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one, and 6-(hydroxymethyl)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H) -one.

7. The composition of claim 6 , wherein the compound of formula (I) is ATT and wherein the effective amount of ATT is greater than 32 mM.

8. The composition of claim 1 , wherein the organic solvent is selected from the group consisting of alcohol, propylene glycol, dimethyl sulfoxide (DMSO), acetonitrile, glycerol, and any combination thereof.

9. The composition of claim 8 , wherein the organic solvent is a combination of ethanol and propylene glycol or a combination of ethanol and glycerol.

10. A method for stabilizing a luminogenic substrate, the method comprising contacting the luminogenic substrate with an effective amount of a compound of formula (I) or a tautomer thereof in the presence of an organic solvent, whereby the luminogenic substrate is stabilized against decomposition,

wherein the luminogenic substrate is coelenterazine or a functional analog thereof;

wherein the compound of formula (I) is

wherein

R 1 is hydrogen, alkyl, substituted alkyl, alkyl-aryl, alkyl-heteroaryl, cycloalkyl, aryl, heteroaryl, carboxylic acid, ester, NR a R b , imine, hydroxyl, or oxo;

R 2 is hydrogen, NR a R b , imine, alkyl, or aryl; and

R a and R b are each independently hydrogen, alkyl, or aryl.

11. The method of claim 10 , wherein the effective amount of the compound of formula (I) is greater than 0.1 mM.

12. The method of claim 10 , wherein the compound of formula (I) is selected from the group consisting of: ATT, ATCA, 3-(4-Amino-5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)propanoic acid, tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione, 4-((2-furylmethylene)amino)-3-mercapto-6-methyl-1,2,4-triazin-5(4H)-one, 6-benzyl-3-sulfanyl-1,2,4-triazin-5-ol, 4-amino-3-mercapto-6-methyl-1,2,4-triazin-5(4H)-one, 3-(5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)propanoic acid, (E)-6-methyl-4-((thiophen-2-ylmethylene)amino)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one, (E)-6-methyl-4-((3-nitrobenzylidene)amino)-3-thioxo -3,4-dihydro-1,2,4-triazin-5(2H)-one, (E)-4-((4-(diethylamino)benzylidene)amino)-6-methyl-3-thioxo -3,4-dihydro-1,2,4-triazin-5(2H)-one, ATCA ethyl ester, TAK-0014, TAK-0002, TAK-0021, TAK -0020, TAK-0018, TAK-0009, TAK-0007, TAK-0008, TAK-0003, TAK-0004, 3-thioxo-6-(trifluoromethyl)-3,4-dihydro-1,2,4-triazin-5(2H) -one, 6-cyclopropyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H) -one, and 6-(hydroxymethyl)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H) -one.

13. The method of claim 12 , wherein the compound of formula (I) is ATT and wherein the effective amount of the ATT is greater than 32 mM.

14. The method of claim 10 , wherein luminogenic substrate is stabilized against decomposition in the presence of light, in the absence of light, or at temperatures from −80° C. to 60° C.

15. The method of claim 10 , wherein the functional analog of coelenterazine is furimazine.

16. The method of claim 10 , wherein the organic solvent is selected from the group consisting of alcohol, propylene glycol, dimethyl sulfoxide (DMSO), acetonitrile, glycerol, and any combination thereof.

17. A kit comprising the composition of claim 1 in a single container, wherein the compound of formula (I) stabilizes the luminogenic substrate.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2015
From: KIRKLAND, THOMAS; WOOD, KEITH V.; HALL, MARY; SCHWINN, MARIE
To: PROMEGA CORPORATION
Reel/Frame 035714/0157 →